Tehran University of Medical Sciences

Science Communicator Platform

Share By
Thiolated Carboxymethyl Dextran As a Nanocarrier for Colon Delivery of Hset1 Antisense: In Vitro Stability and Efficiency Study Publisher Pubmed



Kiani M1 ; Mirzazadeh Tekie FS1 ; Dinarvand M1 ; Soleimani M2, 3 ; Dinarvand R1, 4 ; Atyabi F1, 4
Authors

Source: Materials Science and Engineering C Published:2016


Abstract

Gene therapy is an optimistic approach in cancer treatment. However, for efficient delivery of gene materials, designing an appropriate vector is necessary. Polyelectrolyte complexes (PECs) of chitosan and dextran could be considered a proper nanoparticulate carrier for sensitive biomaterials. In this study, PECs of chitosan and thiolated dextran were used as either an injectable or oral gene delivery system. hSET1 antisense was loaded into the PECs to suppress proliferation of colon cancer cell line. The prepared nanoparticles have ~ 115 nm diameter size and positive zeta potential with high mucoadhesion properties. They are able to protect antisense from degradation in serum and biorelevant fluids (FaSSIF and FaSSGF). Furthermore, prepared nanoparticles demonstrated superior cellular penetration and inhibitory effect on SW480 colon cancer cell proliferation. All nanoparticles significantly down regulated hSET1 in comparison with naked antisense. It can be concluded that thiolated PECs have potential use for injectable or oral delivery of nucleic acids such as antisense. © 2016 Elsevier B.V. All rights reserved.
Other Related Docs
5. Optimization of Chitosan Nanoparticles As an Anti-Hiv Sirna Delivery Vehicle, International Journal of Biological Macromolecules (2019)
15. Nanocarrier-Based Gene Delivery for Immune Cell Engineering, Journal of Materials Chemistry B (2024)
16. Peptide-Functionalized Polymeric Nanoparticles for Delivery of Curcumin to Cancer Cells, Journal of Drug Delivery Science and Technology (2024)
17. Chitosan and Wnt/Β-Catenin Signaling Pathways in Different Cancers, Combinatorial chemistry & high throughput screening (2021)
19. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)